Sharecare Inc has a consensus price target of $1.24 based on the ratings of 16 analysis. The 3 most-recent analyst ratings were released by Morgan Stanley, Canaccord Genuity, and Canaccord Genuity on June 24, 2024, June 21, 2024, and May 21, 2024, respectively. With an average price target of $1.62 between Morgan Stanley, Canaccord Genuity, and Canaccord Genuity, there's an implied 18.25% upside for Sharecare Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/24/2024 | Buy Now | 4.38% | Morgan Stanley | Craig Hettenbach | $1 → $1.43 | Maintains | Equal-Weight | Get Alert |
06/21/2024 | Buy Now | 4.38% | Canaccord Genuity | Richard Close | $2 → $1.43 | Downgrade | Buy → Hold | Get Alert |
05/21/2024 | Buy Now | 45.99% | Canaccord Genuity | Richard Close | $2 → $2 | Maintains | Buy | Get Alert |
04/15/2024 | Buy Now | -27.01% | Morgan Stanley | Craig Hettenbach | $1.5 → $1 | Maintains | Equal-Weight | Get Alert |
04/01/2024 | Buy Now | — | BTIG | David Larsen | — | Downgrade | Buy → Neutral | Get Alert |
06/02/2023 | Buy Now | 264.96% | BTIG | David Larsen | → $5 | Reiterates | → Buy | Get Alert |
03/30/2023 | Buy Now | 45.99% | Morgan Stanley | Craig Hettenbach | $2.5 → $2 | Maintains | Equal-Weight | Get Alert |
11/11/2022 | Buy Now | 118.98% | Canaccord Genuity | Richard Close | $4 → $3 | Maintains | Buy | Get Alert |
10/05/2022 | Buy Now | 264.96% | BTIG | David Larsen | $8 → $5 | Maintains | Buy | Get Alert |
09/21/2022 | Buy Now | 53.28% | Goldman Sachs | Cindy Motz | $1.5 → $2.1 | Maintains | Neutral | Get Alert |
07/20/2022 | Buy Now | 82.48% | Morgan Stanley | Craig Hettenbach | → $2.5 | Initiates | → Equal-Weight | Get Alert |
04/01/2022 | Buy Now | 629.93% | BTIG | David Larsen | $15 → $10 | Maintains | Buy | Get Alert |
04/01/2022 | Buy Now | 191.97% | Goldman Sachs | Cindy Motz | $4.5 → $4 | Maintains | Neutral | Get Alert |
02/11/2022 | Buy Now | — | Goldman Sachs | Cindy Motz | — | Initiates | → Neutral | Get Alert |
08/04/2021 | Buy Now | 702.92% | Canaccord Genuity | Richard Close | — | Initiates | → Buy | Get Alert |
07/28/2021 | Buy Now | 994.89% | BTIG | David Larsen | — | Initiates | → Buy | Get Alert |
The latest price target for Sharecare (NASDAQ:SHCR) was reported by Morgan Stanley on June 24, 2024. The analyst firm set a price target for $1.43 expecting SHCR to rise to within 12 months (a possible 4.38% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Sharecare (NASDAQ:SHCR) was provided by Morgan Stanley, and Sharecare maintained their equal-weight rating.
There is no last upgrade for Sharecare
The last downgrade for Sharecare Inc happened on June 21, 2024 when Canaccord Genuity changed their price target from $2 to $1.43 for Sharecare Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sharecare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sharecare was filed on June 24, 2024 so you should expect the next rating to be made available sometime around June 24, 2025.
While ratings are subjective and will change, the latest Sharecare (SHCR) rating was a maintained with a price target of $1.00 to $1.43. The current price Sharecare (SHCR) is trading at is $1.37, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.